Vsee Health (VSEE) Cost of Revenue (2023 - 2026)

Vsee Health (VSEE) has reported Cost of Revenue for 4 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue rose 208.02% year-over-year to $1.4 million; the trailing twelve-month figure through Jun 2026 stood at $7.3 million (up 91.31% YoY), and the FY2025 full-year result was $7.3 million, up 123.88% from the prior year.
• Cost of Revenue declined to $1.4 million in Q2 2026 per VSEE's latest filing, from $2.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.1 million in Q4 2025 and bottomed at $386253.0 in Q1 2024.
• Historically, Cost of Revenue has averaged $1.0 million across 4 years, with a median of $575322.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue tumbled 32.86% in 2024, then soared 278.38% in 2025.
• Over 4 years, Cost of Revenue stood at $405187.0 in 2023, then surged by 233.97% to $1.4 million in 2024, then soared by 54.57% to $2.1 million in 2025, then sank by 35.19% to $1.4 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $1.4 million, $2.0 million, and $2.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.